マーケットレポート詳細

血漿製剤：世界市場2027年予測

Global Markets for Blood Plasma Products

出版元：BCC Research　 出版元について
発行年：2023年2月
定価 Single User License(1名様ライセンス)US$5,500 (米国ドル) /2 to 5 Users License(5名様)$6,600 /Site License $7,920 / Enterprise License $9,504
ご予算に応じた各種ご提案も承ります。詳細はお問い合わせください。
ご請求は円換算（お見積り日TTSレート）となります。
納品形態：PDF by Email
当調査レポートは英文144ページになります。
商品コード：BCC451

お問い合わせ、お見積りのリクエストは下のボタンをクリックしてご入力ください。

【レポート紹介】

血漿製剤の世界市場規模は、2022年の332億ドルから今後2027年には457億ドルへと拡大が予測されます。2022年から2027年にかけての同市場規模の平均年成長率は6.6%とレポートは分析しています。
当レポートでは、血漿製剤の市場概要、市場ダイナミクス、地域別市場分析、主要企業プロフィールなどを盛り込み、概略以下の構成でお届けいたします。

【レポート構成概要】

◆イントロダクション

・調査目的
・調査対象
・調査手法

◆サマリーと調査ハイライト

◆市場/技術背景

・イントロダクション
・血漿の成分
・血漿の機能
・献血
・臨床ガイドライン
・市場ダイナミクス

◆血漿製剤市場：製品タイプ別

免疫グロブリン
・静注用
・皮下注用
・その他
アルブミン
凝固因子濃縮製剤
高度免疫グロブリン
その他
※市場予測データ掲載-2027年

◆血漿製剤市場：用途別

・神経学
・免疫学
・腫瘍学
・移植
・血液学
・リウマチ学
・呼吸器学
・その他
※市場予測データ掲載-2027年

◆血漿製剤市場：エンドユーザー別

・病院/クリニック
・研究所
・学術機関
・輸血センター
※市場予測データ掲載-2027年

◆血漿製剤：地域別

・北米
・欧州
・アジア太平洋
・その他地域
※地域別に主要国別の細分化データ掲載
※地域別に全セグメント別の市場予測データ掲載

◆血漿製剤の投与方法

・輸液
・ゲル
・スプレー
・バイオメディカルシーラント
・その他投与方法

◆血漿製剤市場へのCOVID-19の影響

・血漿製剤への影響

◆競合状況

・概要
・主要企業/市場シェア
・ファイブフォース分析
・主要開発
・製品の発売
・合併/買収
・事業拡大
・契約/コラボレーション

◆血漿製剤の主要企業プロフィール

・ADMA BIOLOGICS INC.
・BAXTER INTERNATIONAL
・BIO PRODUCTS LABORATORY LTD. (BPL)
・CHINA BIOLOGIC PRODUCTS INC.
・CSL BEHRING
・GRIFOLS INTERNATIONAL SA
・INNOVATIVE RESEARCH INC.
・INTAS PHARMACEUTICALS LTD.
・KEDRION SPA
・LFB SA
・OCTAPHARMA AG
・SANQUIN
・武田薬品工業株式会社

（全144頁）


【レポート詳細目次、データ項目一覧は当ページ下を参照ください】

Table of Contents (英文詳細目次）

Chapter 1 Introduction

1.1 Study Goals and Objectives
1.2 Reasons for Doing This Study
1.3 Scope of Report
1.4 What's New in This Update?
1.5 Information Sources
1.6 Methodology
1.7 Intended Audience
1.8 Geographic Breakdown
1.9 Analyst's Credentials
1.10 BCC Custom Research
1.11 Related BCC Research Reports

Chapter 2 Summary and Highlights

2.1 Highlights of the Market for Blood Plasma Products

Chapter 3 Market and Technology Background

3.1 Introduction to Blood Plasma Products
3.2 Components of Blood Plasma
3.3 Functions of Blood Plasma
3.4 Blood Donation

  • 3.4.1 Collection and Extraction of Blood Plasma
  • 3.4.2 Fractionation Methods for Extracting Individual Components from Plasma

3.5 Government Regulations: FDA, International Regulatory Agencies and Medical Associations
3.6 Clinical Guidelines
3.7 Market Dynamics

  • 3.7.1 Drivers
  • 3.7.2 Restraints
  • 3.7.3 Opportunities

Chapter 4 Market Breakdown by Product Type

4.1 Overall Market Size and Forecast
4.2 Immunoglobulins

  • 4.2.1 Market Size and Forecast by Region
  • 4.2.2 Market Size and Forecast by Product Subsegment

4.3 Albumin

  • 4.3.1 Market Size and Forecast by Region

4.4 Coagulation Factor Concentrates

  • 4.4.1 Market Size and Forecast by Region

4.5 Hyperimmune Globulins

  • 4.5.1 Market Size and Forecast by Region

4.6 Other Plasma Fractionation Products

  • 4.6.1 Market Size and Forecast by Region

Chapter 5 Market Breakdown by Application

5.1 Overall Market Size and Forecast
5.2 Neurology

  • 5.2.1 Market Size and Forecast by Region

5.3 Immunology

  • 5.3.1 Market Size and Forecast by Region

5.4 Oncology

  • 5.4.1 Market Size and Forecast by Region

5.5 Transplants

  • 5.5.1 Market Size and Forecast by Region

5.6 Hematology

  • 5.6.1 Market Size and Forecast by Region

5.7 Rheumatology

  • 5.7.1 Market Size and Forecast by Region

5.8 Pulmonology

  • 5.8.1 Market Size and Forecast by Region

5.9 Others

  • 5.9.1 Market Size and Forecast by Region

Chapter 6 Market Breakdown by End User

6.1 Overall Market Size and Forecast
6.2 Hospitals and Clinics

  • 6.2.1 Market Size and Forecast by Region

6.3 Research Laboratories

  • 6.3.1 Market Size and Forecast by Region

6.4 Academic Institutions

  • 6.4.1 Market Size and Forecast by Region

6.5 Blood Transfusion Centers

  • 6.5.1 Market Size and Forecast by Region

Chapter 7 Market Breakdown by Region

7.1 Overall Market Size and Forecast by Region
7.2 North America

  • 7.2.1 North American Market Size and Forecast by Country
  • 7.2.2 North American Market Size and Forecast by Product Type
  • 7.2.3 North American Market Size and Forecast by Application
  • 7.2.4 North American Market Size and Forecast by End User

7.3 Europe

  • 7.3.1 European Market Size and Forecast by Country
  • 7.3.2 European Market Size and Forecast by Product Type
  • 7.3.3 European Market Size and Forecast by Application
  • 7.3.4 European Market Size and Forecast by End User

7.4 Asia-Pacific

  • 7.4.1 Asia-Pacific Market Size and Forecast by Country
  • 7.4.2 APAC Market Size and Forecast by Product Type
  • 7.4.3 APAC Market Size and Forecast by Application
  • 7.4.4 APAC Market Size and Forecast by End User

7.5 Rest of the World

  • 7.5.1 Rest of the World Market Size and Forecast by Country
  • 7.5.2 RoW Market Size and Forecast by Product Type
  • 7.5.3 RoW Market Size and Forecast by Application
  • 7.5.4 RoW Market Size and Forecast by End User

Chapter 8 Mode of Delivery for Blood Plasma Products

8.1 Infusion Solutions
8.2 Gels
8.3 Sprays
8.4 Biomedical Sealants
8.5 Other Modes of Delivery

  • 8.5.1 Inhalation
  • 8.5.2 Ophthalmic Drops

Chapter 9 Patent Review and Clinical Trial Landscape

9.1 Patent Review
9.2 Clinical Trials Landscape

Chapter 10 Impact of the COVID-19 Pandemic on the Market for Blood Plasma Products

10.1 Impact on the Blood Plasma Product Manufacturers

Chapter 11 Competitive Landscape

11.1 Overview
11.2 Major Players and Market Shares
11.3 Porter's Five Forces Analysis of the Market for Blood Plasma Products

  • 11.3.1 Bargaining Power of Suppliers
  • 11.3.2 Bargaining Power of Buyers
  • 11.3.3 The Threat of New Suppliers
  • 11.3.4 Threat of Substitutes
  • 11.3.5 Competitive Rivalry/Degree of Competition

11.4 Major Developments
11.5 Product Launches
11.6 Mergers and Acquisitions
11.7 Business Expansions
11.8 Agreements and Collaborations

Chapter 12 Company Profiles

ADMA BIOLOGICS INC.
BAXTER INTERNATIONAL
BIO PRODUCTS LABORATORY LTD. (BPL)
CHINA BIOLOGIC PRODUCTS INC.
CSL BEHRING
GRIFOLS INTERNATIONAL SA
INNOVATIVE RESEARCH INC.
INTAS PHARMACEUTICALS LTD.
KEDRION SPA
LFB SA
OCTAPHARMA AG
SANQUIN
TAKEDA PHARMACEUTICAL CO. LTD.

List of Tables

Summary Table : Global Market for Blood Plasma Products, by Product Type, Through 2027
Table 1 : Blood Plasma Components
Table 2 : Percentage of Major Proteins Present in Different Fractions After Cohn’s Fractionation Method
Table 3 : Overview of Plasma Collection Operations Across Various Countries
Table 4 : Global Market for Blood Plasma Products, by Product Type, Through 2027
Table 5 : Global Market for Immunoglobulins, by Region, Through 2027
Table 6 : Global Market for Immunoglobulins, by Product Subsegment, Through 2027
Table 7 : Global Market for Intravenous Immunoglobulin, by Region, Through 2027
Table 8 : Global Market for Subcutaneous Immunoglobulins, by Region, Through 2027
Table 9 : Global Market for Other Immunoglobulins, by Region, Through 2027
Table 10 : Global Market for Albumins, by Region, Through 2027
Table 11 : Global Market for Coagulation Factor Concentrates, by Region, Through 2027
Table 12 : Global Market for Hyperimmune Globulins, by Region, Through 2027
Table 13 : Key Protease Inhibitors Used in the Treatment of HIV
Table 14 : Global Market for Other Plasma Fractionation Products, by Region, Through 2027
Table 15 : Global Market for Blood Plasma Products, by Application, Through 2027
Table 16 : Global Market for the Application of Blood Plasma Products in Neurology, by Region, Through 2027
Table 17 : Global Market for the Application of Blood Plasma Products in Immunology, by Region, Through 2027
Table 18 : Global Market for the Application of Blood Plasma Products in Oncology, by Region, Through 2027
Table 19 : Global Market for the Application of Blood Plasma Products in Transplants, by Region, Through 2027
Table 20 : Global Market for the Application of Blood Plasma Products in Hematology, by Region, Through 2027
Table 21 : Global Market for the Application of Blood Plasma Products in Rheumatology, by Region, Through 2027
Table 22 : Global Market for the Application of Blood Plasma Products in Pulmonology, by Region, Through 2027
Table 23 : Global Market for the Application of Blood Plasma Products in Other Areas, by Region, Through 2027
Table 24 : Global Market for Blood Plasma Products, by End User, Through 2027
Table 25 : Global Market for Blood Plasma Products Used in Hospitals and Clinics, by Region, Through 2027
Table 26 : Global Market for Blood Plasma Products Used in Research Laboratories, by Region, Through 2027
Table 27 : Global Market for Blood Plasma Products Used in Academic Institutions, by Region, Through 2027
Table 28 : Global Market for Blood Plasma Products Used in Blood Transfusion Centers, by Region, Through 2027
Table 29 : Global Market for Blood Plasma Products, by Region, Through 2027
Table 30 : North American Market for Blood Plasma Products, by Country, Through 2027
Table 31 : North American Market for Blood Plasma Products, by Product Type, Through 2027
Table 32 : North American Market for Immunoglobulins, by Product Subsegment, Through 2027
Table 33 : North American Market for Blood Plasma Products, by Application, Through 2027
Table 34 : North American Market for Blood Plasma Products, by End User, Through 2027
Table 35 : European Patients in Need of Plasma Protein Therapies
Table 36 : European Market for Blood Plasma Products, by Country, Through 2027
Table 37 : European Market for Blood Plasma Products, by Product Type, Through 2027
Table 38 : European Market for Immunoglobulins, by Product Subsegment, Through 2027
Table 39 : European Market for Blood Plasma Products, by Application, Through 2027
Table 40 : European Market for Blood Plasma Products, by End User, Through 2027
Table 41 : Asia-Pacific Market for Blood Plasma Products, by Country, Through 2027
Table 42 : Asia-Pacific Market for Blood Plasma, by Product Type, Through 2027
Table 43 : Asia-Pacific Market for Immunoglobulins, by Product Subsegment, Through 2027
Table 44 : Asia-Pacific Market for Blood Plasma Products, by Application, Through 2027
Table 45 : Asia-Pacific Market for Blood Plasma Products, by End User, Through 2027
Table 46 : Rest of the World Market for Blood Plasma Products, by Product Type, Through 2027
Table 47 : Rest of the World Market for Immunoglobulins, by Product Subsegment, Through 2027
Table 48 : Rest of the World Market for Blood Plasma Products, by Application, Through 2027
Table 49 : Rest of the World Market for Blood Plasma Products, by End User, Through 2027
Table 50 : Key Patents Filed on Various Blood Plasma Products, by Competitor Companies, 2019-2022
Table 51 : Clinical Trial Activities of Key Competitors on Various Blood Plasma Products
Table 52 : Porter’s Five Forces Analysis: Global Market for Blood Plasma Products
Table 53 : Product Launches in the Global Market for Blood Plasma Products, by Key Competitors, 2020-2022
Table 54 : Mergers and Acquisitions of Key Competitors in the Global Market for Blood Plasma Products, 2020-2022
Table 55 : Business Expansion Activities in the Global Market for Blood Plasma Products, by Key Competitors, 2020-2022
Table 56 : Agreements and Collaborations Activities in the Global Market for Blood Plasma Products, by Key Competitors, 2020-2022
Table 57 : ADMA Biologics Inc.: Product Portfolio
Table 58 : ADMA Biologics Inc.: Developments and Strategies, 2022
Table 59 : Bio Products Laboratory Ltd.: Product Portfolio
Table 60 : Bio Products Laboratory Ltd.: Developments and Strategies, 2021 and 2022
Table 61 : China Biologic Products Inc.: Product Portfolio
Table 62 : China Biologic Products Inc.: Developments and Strategies, 2020
Table 63 : CSL Behring: Product Portfolio
Table 64 : CSL Behring: Developments and Strategies, 2021 and 2022
Table 65 : Grifols International SA: Product Portfolio
Table 66 : Grifols International SA: Developments and Strategies, 2020-2022
Table 67 : Kedrion SpA: Product Portfolio
Table 68 : Kedrion SpA: Developments and Strategies, 2020-2022
Table 69 : LFB SA: Developments and Strategies, 2021 and 2022
Table 70 : Octapharma AG: Product Portfolio
Table 71 : Octapharma AG: Developments and Strategies, 2021 and 2022
Table 72 : Takeda Pharmaceutical Co. Ltd.: Product Portfolio
Table 73 : Takeda Pharmaceutical Co. Ltd.: Developments and Strategies, 2022

List of Figures

Summary Figure : Global Market for Blood Plasma Products, by Product Type, 2019-2027
Figure 1 : Role of Albumin Concentration in Maintaining Osmotic Pressure
Figure 2 : Benefits of Blood Donation to the Donor
Figure 3 : Supply Chain of Blood Plasma Products Market
Figure 4 : FDA Regulation for Approval of Blood Products and Devices
Figure 5 : Global Market for Blood Plasma Products, by Product Type, 2019-2027
Figure 6 : Global Market Shares of Blood Plasma Products, by Product Type, 2021
Figure 7 : Subsegments of the Market for Immunoglobulin Products
Figure 8 : Global Market Shares of Immunoglobulins, by Region, 2021
Figure 9 : Global Market Shares of Immunoglobulins, by Product Subsegment, 2021
Figure 10 : Global Market Shares of Intravenous Immunoglobulin, by Region, 2021
Figure 11 : Categorization of Subcutaneous Immunoglobulin
Figure 12 : Global Market Shares of Subcutaneous Immunoglobulins, by region, 2021
Figure 13 : Global Market Shares of Other Immunoglobulins, by Region, 2021
Figure 14 : Global Market Shares of Albumins, by Region, 2021
Figure 15 : Global Market Shares of Coagulation Factor Concentrates, by Region, 2021
Figure 16 : Process of the Isolation of Hyperimmune Globulin
Figure 17 : Global Market Shares of Hyperimmune Globulins, by Region, 2021
Figure 18 : Global Market Shares of Other Plasma Fractionation Products, by Region, 2021 (%)
Figure 19 : Global Market for Blood Plasma Products, by Application, 2019-2027
Figure 20 : Global Market Shares of Blood Plasma Products, by Application, 2021
Figure 21 : Role of Plasma Exchange in the Treatment of Neuroimmunological Disorders
Figure 22 : Functions of the Immune System
Figure 23 : Conditions Engendering Blood Transfusions
Figure 24 : Categories of Bleeding Disorders
Figure 25 : Symptoms of Lupus Infection
Figure 26 : Global Market Shares of Blood Plasma Products, by End User, 2021
Figure 27 : Role of Platelet-Rich Plasma in Treatment
Figure 28 : Global Market for Blood Plasma Products Used in Blood Transfusion Centers, by Region, Through 2027
Figure 29 : Global Market for Blood Plasma Products, by Region, 2019-2027
Figure 30 : Global Market Shares of Blood Plasma Products, by Region, 2021
Figure 31 : North American Market Shares of Blood Plasma Products, by Country, 2021
Figure 32 : U.S. Market for Blood Plasma Products, 2019-2027
Figure 33 : Canadian Market for Blood Plasma Products, 2019-2027
Figure 34 : European Market for Blood Plasma Products, by Country, 2019-2027
Figure 35 : European Market Shares of Blood Plasma Products, by Country, 2021
Figure 36 : German Market for Blood Plasma Products, 2019-2027
Figure 37 : French Market for Blood Plasma Products, 2019-2027
Figure 38 : Italian Market for Blood Plasma Products, 2019-2027
Figure 39 : U.K. Market for Blood Plasma Products, 2019-2027
Figure 40 : Rest of the European Market for Blood Plasma Products, 2019-2027
Figure 41 : Asia-Pacific Market for Blood Plasma Products, by Country, 2019-2027
Figure 42 : Asia-Pacific Market Shares of Blood Plasma Products, by Country, 2021
Figure 43 : Japanese Market for Blood Plasma Products, 2019-2027
Figure 44 : Chinese Market for Blood Plasma Products, 2019-2027
Figure 45 : Indian Market for Blood Plasma Products, 2019-2027
Figure 46 : Australian Market for Blood Plasma Products, 2019-2027
Figure 47 : Rest of Asia-Pacific Market for Blood Plasma Products, 2019-2027
Figure 48 : Rest of the World Market for Blood Plasma Products, 2019-2027
Figure 49 : Frequent Side Effects Associated with Immunoglobulin Infusions
Figure 50 : Rarely Induced Severe Allergic Reactions Associated with Immunoglobulin Infusions
Figure 51 : Procedure for Plasma Gel Treatment
Figure 52 : Role of Fibrin Sealant in Coagulation Cascade
Figure 53 : Global Market Shares of Blood Plasma Products, by Company, 2021
Figure 54 : ADMA Biologics Inc.: Financials, 2020 and 2021
Figure 55 : ADMA Biologics Inc.: Revenue Share, by Business Segment, 2021
Figure 56 : ADMA Biologics Inc.: Market Shares, by Region, 2021
Figure 57 : CSL Behring: Annual Revenue, 2019-2021
Figure 58 : CSL Behring: Market Shares, by Region, 2021
Figure 59 : Grifols International SA: Financials, 2019-2021
Figure 60 : Grifols International SA.: Market Share, by Business Segment, 2021
Figure 61 : Grifols International SA.: Market Share, by Region, 2021
Figure 62 : Kedrion SpA: Financials, 2019-2021
Figure 63 : Kedrion SpA: Revenue Share, by Business Segment, 2021
Figure 64 : Kedrion SpA: Market Share, by Region, 2021
Figure 65 : Octapharma AG: Financials, 2019-2021
Figure 66 : Takeda Pharmaceutical Co. Ltd.: Financials, 2020 and 2021
Figure 67 : Takeda Pharmaceutical Co. Ltd.: Revenue Share, by Region, 2021
Figure 68 : Takeda Pharmaceutical Co. Ltd.: Revenue Share, by Business Segment, 2021


△ 一番上に戻る